GEODE CAPITAL MANAGEMENT, LLC
Position in LFCR — Lifecore Biomedical, Inc. De
CIK 1214717
BOSTON, MA
Position in LFCR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,491,375
+$1,459,178 QoQ
Shares Held
855,500
+5.0% QoQ
Ownership
2.26%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 98 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LFCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. LFCR ranks #37 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,289,622 | $954,992,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
996,598 | $539,986,694 | |
| 3 | VTRS |
Viatris Inc
|
32,807,906 | $520,989,547 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,607,196 | $393,251,799 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,138,777 | $360,469,474 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,302,057 | $278,143,622 | |
| 7 | ALKS |
Alkermes plc.
|
4,477,876 | $234,640,702 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,841,367 | $204,281,254 |
All Filings in LFCR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,491,375 | 855,500 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,032,197 | 815,107 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,377,471 | 779,642 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $5,693,909 | 773,629 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $6,297,002 | 775,493 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $5,283,505 | 750,498 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,095,092 | 685,746 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,946,586 | 597,685 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,780,366 | 541,982 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,523,768 | 286,962 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,764,676 | 285,085 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,083,120 | 275,910 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,771,199 | 286,577 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,861,234 | 492,390 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,014,593 | 465,215 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,130,702 | 464,646 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,769,947 | 478,430 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,459,796 | 471,485 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,117,999 | 461,081 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,156,320 | 450,794 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $5,074,672 | 451,082 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,483,376 | 422,960 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,515,574 | 416,182 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,185,587 | 430,616 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,352,489 | 421,167 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,630,577 | 417,788 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||